These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 19103832)
1. Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years. Sherifali D Evid Based Nurs; 2009 Jan; 12(1):14. PubMed ID: 19103832 [No Abstract] [Full Text] [Related]
2. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years. O'Sullivan EP; Dinneen SF ACP J Club; 2008 Dec; 149(6):4. PubMed ID: 19071870 [No Abstract] [Full Text] [Related]
3. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years. O'Sullivan EP; Dinneen SF Evid Based Med; 2009 Feb; 14(1):9-10. PubMed ID: 19181941 [No Abstract] [Full Text] [Related]
4. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Morales A J Ark Med Soc; 2009 Oct; 106(4):90-3. PubMed ID: 19813399 [TBL] [Abstract][Full Text] [Related]
5. Intensive therapy for diabetes through influence on innate immune system. Li ZZ; Liu JB; Li L; Jiao L; Chen L Med Hypotheses; 2009 Jun; 72(6):675-6. PubMed ID: 19264419 [TBL] [Abstract][Full Text] [Related]
6. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes. Roman G; Hancu N Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921 [TBL] [Abstract][Full Text] [Related]
7. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369 [TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes. Weiss IA; Valiquette G; Schwarcz MD Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678 [TBL] [Abstract][Full Text] [Related]
9. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Gibson BR; Galiatsatos P; Rabiee A; Eaton L; Abu-Hamdah R; Christmas C; Milner SM; Andersen DK; Elahi D Surgery; 2009 Nov; 146(5):922-30. PubMed ID: 19733884 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. Mourad JJ; Le Jeune S J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847 [TBL] [Abstract][Full Text] [Related]
11. Benefits of tight blood pressure control to prevent diabetes complications were not sustained. O'Sullivan EP; Dinneen SF ACP J Club; 2008 Dec; 149(6):5. PubMed ID: 19071871 [No Abstract] [Full Text] [Related]
12. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention. White H; Pollard K; Etherington C; Clifton I; Morton AM; Owen D; Conway SP; Peckham DG J Cyst Fibros; 2009 May; 8(3):179-85. PubMed ID: 19179122 [TBL] [Abstract][Full Text] [Related]
13. Glycemic targets for patients with type 2 diabetes mellitus. Hamnvik OP; McMahon GT Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966 [TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes in primary care in belgium: need for structured shared care. Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093 [TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. Yang M; Guo Q; Zhang X; Sun S; Wang Y; Zhao L; Hu E; Li C Int J Nurs Stud; 2009 Jun; 46(6):753-8. PubMed ID: 19232615 [TBL] [Abstract][Full Text] [Related]
16. Haemophilia care in children--benefits of early prophylaxis for inhibitor prevention. Mancuso ME; Graca L; Auerswald G; Santagostino E Haemophilia; 2009 Jan; 15 Suppl 1():8-14. PubMed ID: 19125935 [TBL] [Abstract][Full Text] [Related]
17. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes. Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924 [TBL] [Abstract][Full Text] [Related]
18. Glucose control in the intensive care unit. Fahy BG; Sheehy AM; Coursin DB Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461 [TBL] [Abstract][Full Text] [Related]
19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
20. Related factors to disparity of diabetes care in Iran. Mirzazadeh A; Baradaran HR; Haghdoost AA; Salari P Med Sci Monit; 2009 May; 15(5):PH32-6. PubMed ID: 19396047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]